Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific...

Area of Science:

• Immunology
• Allergy Research
• T cell Biology

Background:

• Characterizing rare allergen-specific T cells for immunotherapy has been challenging due to limitations in existing methods.
• Previous approaches often required in vitro amplification, potentially altering cell phenotypes.

Purpose of the Study:

• To monitor allergen-specific CD4(+) T cells under physiological conditions.
• To track T cells generated during natural pollen exposure and allergy vaccination.

Main Methods:

• Used peptide-MHC class II tetramers to track and characterize allergen-specific CD4(+) T cells.
• Studied subjects with alder pollen allergy, nonallergic individuals, and those undergoing allergy vaccination.

Main Results:

• Detected allergen-specific CD4(+) T cells in both allergic and nonallergic subjects.
• Identified two distinct CD4(+) T cell subpopulations: CD27(-) pathogenic cells (dominant in allergic individuals) and CD27(+) protective cells (expressing IL-10 and IFN-γ).
• Observed that successful immunotherapy involves deleting CD27(-) cells and inducing IL-10 in CD27(+) cells.

Conclusions:

• Differentiation stage is a key factor in classifying allergen-specific CD4(+) T cells.
• Two distinct subpopulations with unique functions and outcomes during immunotherapy were identified.